Graves’ Orbitopathy Market to Exhibit Growth at a CAGR of 19.8% During the Forecast Period (2025-2034)
The Graves’ orbitopathy market is undergoing rapid change, driven by advancements in targeted treatments. TEPEZZA (teprotumumab-trbw) remains the…